Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot and disrupt the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily. Treatment can continue until the wart is removed, with a maximum duration of up to 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist, due to the increased risk of complications.

Application is contraindicated on irritated, infected, or reddened skin to prevent exacerbation of these conditions.

The product should not be applied to genital warts or warts located on the face, as these areas may require specialized treatment.

Use is also contraindicated on moles, birthmarks, and warts with hair growing from them to avoid potential adverse effects.

Additionally, the product must not be used on mucous membranes, as this may lead to irritation or other complications.

Warnings and Precautions

For external use only, this product is flammable; therefore, it must be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

General precautions should be observed when using this product. It is contraindicated for individuals with diabetes or poor blood circulation unless used under the advice and supervision of a qualified healthcare professional, such as a doctor or podiatrist. The product should not be applied to irritated, infected, or reddened skin, nor should it be used on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it must not be applied to mucous membranes.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Users should discontinue use and consult a healthcare provider if discomfort persists.

Side Effects

Patients should be aware of several important considerations regarding the use of this product. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the advice and supervision of a healthcare professional, such as a doctor or podiatrist.

Common adverse reactions may include skin irritation, infection, or reddening of the skin. Additionally, the product should not be applied to genital warts, facial warts, moles, birthmarks, or warts with hair growing from them, as these conditions may exacerbate adverse effects.

During the use of this product, it is crucial to avoid contact with the eyes. In the event of accidental exposure, patients should flush the eyes with water for 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory discomfort.

Patients are advised to discontinue use and consult a healthcare provider if discomfort persists. Furthermore, this product should be kept out of reach of children. If ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients should be advised against the use of this product, particularly if they have diabetes or poor blood circulation, unless under the guidance and supervision of a healthcare professional. The product is contraindicated for application on irritated, infected, or reddened skin, as well as on genital warts, facial warts, moles, birthmarks, and warts with hair growing from them. It is also not intended for use on mucous membranes and is strictly for external use only. Additionally, due to its flammability, it is essential to keep the product away from fire or flame. The potential risks associated with use during pregnancy have not been established, and caution is advised to ensure the safety of both the patient and the fetus.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not well characterized. It is advisable to monitor breastfed infants for any potential adverse effects if the mother is using this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, patients should be cautioned against using the product on irritated, infected, or reddened skin, as well as on genital warts, warts on the face, moles, birthmarks, and warts with hair growing from them. It is also important to instruct patients not to apply the product to mucous membranes.

Patients should be advised to discontinue use and consult a doctor if discomfort persists after application. Furthermore, when using this product, patients should be reminded to avoid contact with their eyes. In case of contact, they should flush the eyes with water for at least 15 minutes. Lastly, patients should be cautioned to avoid inhaling vapors while using the product.

Storage and Handling

The product is supplied in a tightly capped bottle, which should be stored at room temperature, away from heat sources. It is essential to maintain the storage temperature between 20°C to 30°C (68°F to 86°F). Additionally, the product must be kept away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)